July 6, 2023 Comments Off on New patent for Mylan Ireland drug YUPELRI Posted in: Patent Added Annual Drug Patent Expirations for YUPELRI Yupelri is a drug marketed by Mylan Ireland Ltd and is included in one NDA. It is available from one supplier. There are seventeen…
The post New patent for Mylan Ireland drug YUPELRI appeared first on DrugPate…
July 6, 2023 Comments Off on New patent for Oncopeptides Ab drug PEPAXTO Posted in: Patent Added Annual Drug Patent Expirations for PEPAXTO Pepaxto is a drug marketed by Oncopeptides Ab and is included in one NDA. There are six patents protecting this drug. This drug has…
The post New patent for Oncopeptides Ab drug PEPAXTO appeared first on DrugP…
